These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11679977)

  • 1. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
    Boya P; Larrea E; Sola I; Majano PL; Jiménez C; Civeira MP; Prieto J
    Hepatology; 2001 Nov; 34(5):1041-8. PubMed ID: 11679977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
    Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of the nuclear factor kappa B--key role in oncogenesis? Chronic hepatitis C virus infection and lymphomagenesis].
    Gasztonyi B; Pár A; Kiss K; Kereskai L; Szomor A; Szeberényi J; Pajor L; Mózsik G
    Orv Hetil; 2003 May; 144(18):863-8. PubMed ID: 12785239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
    Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
    Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
    Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
    J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between NF-kappa B binding activity and expression of PPAR gamma-mRNA in the livers of rats with fatty liver disease].
    Zhao CY; Wang JB; Deng ZJ; Liu JW; Li JM; Li L; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):96-100. PubMed ID: 15727693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
    Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
    J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 expression in HCV-associated chronic liver diseases.
    Shiraki K; Sugimoto K; Okano H; Wagayama H; Fujikawa K; Yamanaka T; Ito T; Ohmori S; Sakai T; Takase K; Nakano T
    Int J Mol Med; 2006 Oct; 18(4):559-63. PubMed ID: 16964404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
    Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
    Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
    Gaweco AS; Wiesner RH; Porayko M; Rustgi VK; Yong S; Hamdani R; Harig J; Chejfec G; McClatchey KD; Van Thiel DH
    Hepatology; 2000 May; 31(5):1183-91. PubMed ID: 10796896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication.
    Rance E; Tanner JE; Alfieri C
    J Viral Hepat; 2012 Feb; 19(2):e73-80. PubMed ID: 22239529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.